Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study.
about
A three gene-based risk score predicts prognosis of resected non-small-cell lung cancerFeasibility study of adjuvant chemotherapy of S-1 and carboplatin for completely resected non-small cell lung cancer.Overexpression of both platelet-derived growth factor-BB and vascular endothelial growth factor-C and its association with lymphangiogenesis in primary human non-small cell lung cancerLong-term survival outcomes by smoking status in surgical and nonsurgical patients with non-small cell lung cancer: comparing never smokers and current smokers.Prognostic impact of serum CYFRA 21-1 in patients with advanced lung adenocarcinoma: a retrospective study.Role of adenovirus-mediated retinoblastoma 94 in the treatment of human non-small cell lung cancer.Clinical significance in the number of involved lymph nodes in patients that underwent surgery for pathological stage III-N2 non-small cell lung cancerHeterogeneous prognosis and adjuvant chemotherapy in pathological stage I non-small cell lung cancer patients.Clinical Characteristics of Resected T3 Non-small Cell Lung Cancer Characterized by Parietal Pleural Invasion or Chest Wall Invasion.Survival after resection for primary lung cancer: a population based study of 3211 resected patientsStereotactic ablative body radiotherapy (SABR) for primary and secondary lung tumours.Changes in the demographics and prognoses of patients with resected non-small cell lung cancer: a 20-year experience at a single institution in Korea.Patient outcomes of monotherapy with hypofractionated three-dimensional conformal radiation therapy for stage T2 or T3 non-small cell lung cancer: a retrospective study.Post-recurrence survival of patients with non-small-cell lung cancer after curative resection with or without induction/adjuvant chemotherapy.Prognostic Factors for Survival of Stage IB Upper Lobe Non-small Cell Lung Cancer Patients: A Retrospective Study in Shanghai, China.Adjuvant chemotherapy plus radiotherapy is superior to chemotherapy following surgical treatment of stage IIIA N2 non-small-cell lung cancerA randomised phase II trial of preoperative chemotherapy of cisplatin-docetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer results of a Japan Clinical Oncology Group trial (JCOG 0204)Prognostic potential of ERCC1 protein expression and clinicopathologic factors in stage III/N2 non-small cell lung cancer.Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer.Surgical Intervention Improves Survival for Metastatic Non-Small Cell Lung Cancer Patients.Prognostic factors in non-small cell lung cancer patients who received neoadjuvant therapy and curative resection.Completely resected n0 non-small cell lung cancer: prognostic factors affecting long-term survivalDecreased SARI expression predicts poor prognosis of Chinese patients with non-small cell lung cancer.Controversies in the management of stage IIIA non-small-cell lung cancer.Association between epithelial-mesenchymal transition and cancer stemness and their effect on the prognosis of lung adenocarcinoma.Lung cancer-associated tumor antigens and the present status of immunotherapy against non-small-cell lung cancer.Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer.Chronological changes in lung cancer surgery in a single Japanese institution.Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer.Prognostic factors for patients in postoperative brain metastases from surgically resected non-small cell lung cancer.Risk assessment of lung resection for lung cancer according to pulmonary function: republication of systematic review and proposals by guideline committee of the Japanese association for chest surgery 2014.Implementation of modern therapy approaches and research for non-small cell lung cancer in Japan.Evolution in the Surgical Care of Patients With Non-Small Cell Lung Cancer in the Mid-South Quality of Surgical Resection Cohort.Distinct outcome of stage I lung adenocarcinoma with ACTN4 cell motility gene amplification.Genetically engineered humanized anti-ganglioside GM2 antibody against multiple organ metastasis produced by GM2-expressing small-cell lung cancer cells.Enhancer of zeste homolog 2 is a novel prognostic biomarker in nonsmall cell lung cancer.Prognostic significance of lymphovascular invasion for patients with stage I non-small cell lung cancer.Predictors of non-neoplastic lesions in lung tumours showing ground-glass opacity on thin-section computed tomography based on a multi-institutional prospective study†.Effect of age on the efficacy of adjuvant chemotherapy for resected non-small cell lung cancer.Insulin-like growth factor receptor-1 expression predicts postoperative recurrence in adenocarcinoma of the lung.
P2860
Q28385148-ACBB276D-6986-474A-8446-84B5C96E45CAQ33408830-E38C7215-6E85-408A-85DF-40A6793D3D5CQ33859145-E4B8B3BF-3217-485F-ACBB-1EAE973EE7CDQ34130681-FEDA36A4-9FA5-4DB5-B3E6-7908D03D7E66Q34860000-F96AAE50-B3FF-46AB-B346-7F00F2BBB390Q35201876-36D3FD3D-2E80-4766-89E4-91B15A3214A1Q35540726-75053494-C86B-4942-8BEF-D9A6D8673502Q36051720-609502E6-D6E4-4B21-80B8-4C65AF02D40FQ36064193-5FB93902-D199-45F8-8AB4-D4B9373146C3Q36184131-36C9081B-5CEE-4267-827C-B077ACB4637CQ36286591-692DC77B-8309-4954-AFDC-4593474E375CQ36472952-0AE80074-865F-4624-9BA6-8886E4E1ED7CQ36476212-7F63D22D-EA05-4B4E-B607-6510691B7196Q36543892-3BF54DF7-83A2-46DB-AFE5-B1F140E0E791Q36551088-B49F37C8-09DD-422D-A957-F12AEA0E1F39Q36631535-CB1E3F10-A9F3-4D2C-86D3-153D0E5E67BDQ36882714-94B75722-A070-496C-A061-1758C07BBCB3Q36926560-D8368F89-8E0C-480C-BD58-56FAD4A4E634Q36946823-A3DEACCB-BAA4-42BE-B200-B778CD45353FQ36993013-F3F9DDDD-B62E-43C7-AB09-1733EC20727DQ37121347-767E06A0-8268-415E-B211-F20716B15B8CQ37171930-B2612DB1-83E2-4760-812A-3B26892DCFB7Q37228817-9D65B602-3C31-4518-906C-59775D5CE15CQ37338248-1A402B1F-3F37-4C04-A46F-8BEC44C173E6Q37441567-9B3BF70F-04C0-44CF-B6BB-FBD186C97D4AQ37598077-6210E0B7-7FC7-47C8-BD28-8979AEF260EAQ37632126-0F6813BC-3A1C-4A68-B33A-81CE0A76127DQ37696710-6A18A03B-E184-44EE-9D2F-25AC03C4CA90Q37711669-D80B0BF9-9C2D-4450-A5CB-416B4BCFD561Q38067307-1EA6D2E2-0402-4C25-8592-3DA9A61B26BDQ38254528-D715E62C-A27C-42F5-BB5D-7989F80C1ADFQ38320914-E8B4482F-94E6-4FF3-9A1B-A9EF23DE7BDCQ38690568-BAAEED85-2533-45F3-A50F-ECABC02467BAQ39117932-B2CE85BF-C36B-4833-8F1C-6CBEA71044DDQ39478999-1BE6FE8A-8AA1-4A2F-995F-A90556850EBDQ39491238-70AF0541-D0F8-4124-8B87-65D4C09C93FBQ39693900-46BAB2AE-E961-44CF-9D20-3AEE36BA2AD9Q40925473-14B5720C-B5F0-4327-AF3A-01CF422B63FFQ41073858-B54D9FAB-D5A7-4443-A609-74FD757B6E07Q42160729-AD4B932B-6EB3-44AA-AC18-B57036E7857D
P2860
Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Prognosis of 6644 resected non ...... se lung cancer registry study.
@en
type
label
Prognosis of 6644 resected non ...... se lung cancer registry study.
@en
prefLabel
Prognosis of 6644 resected non ...... se lung cancer registry study.
@en
P2093
P1433
P1476
Prognosis of 6644 resected non ...... se lung cancer registry study.
@en
P2093
Etsuo Miyaoka
Harubumi Kato
Hirokuni Yoshimura
Hisao Asamura
Japanese Joint Committee of Lung Cancer Registry
Kaoru Shimokata
Ryosuke Tsuchiya
Tomoyuki Goya
Toshimichi Miya
Yasunori Sohara
P304
P356
10.1016/J.LUNGCAN.2005.05.021
P577
2005-08-02T00:00:00Z